Autor/es reacciones

Lluís Montoliu

Research professor at the National Biotechnology Centre (CNB-CSIC) and at the CIBERER-ISCIII

 

Humans, in general, are not consanguineous; we do not share all the same genetic variants. We know that, in humans, consanguinity, inbreeding, and the birth of children to closely related relatives (such as siblings) is strongly discouraged, as it increases the risk of disease due to the presence of mutations in the same genes inherited from both the father and the mother in a single individual. Let’s remember that we share 99.9% of our genome with any other human being; in other words, we differ by 0.1%. But this seemingly small amount conceals a significant number of nucleotides—the letters of our genome—with no fewer than three to six million positions differing when we compare one person to another. And this makes us, fortunately, unique individuals who differ in detail, even though we share the vast majority of the genome in substance.

With mice, the situation is different. Rodents, and mice in particular, do not face the same issues of inbreeding and tolerate inbreeding well. For this reason, researchers have become accustomed to using inbred lines—strains of mice that are practically genetically identical to one another, the result of many consecutive crosses between siblings—until a specific genome is established and maintained that is essentially the same in all individuals within the same colony. Since all individuals in the colony are genetically so similar, the benefit is that experiments have less variability (we almost eliminate individual differences), which means we can use fewer animals in experiments to detect, if any, statistically significant differences in the parameter we are studying.

The problem is that there is not a single strain of mice, but rather hundreds of inbred strains. Within each strain, all individuals are extremely similar, but if we compare the genome of one mouse strain with that of another, we will find many genetic differences. To complicate matters further, we must also account for the spontaneous mutations that constantly arise in any living organism, including mice (this is called genetic drift). If we take a group of mice from a specific strain, split it into two groups to create two different colonies at two different research centers, and keep them by breeding them separately, they will eventually become slightly different, as they will accumulate genetic mutations that are not the same. These differences will increase the longer the two groups of mice from the same strain remain separated. Thus, two researchers may believe they are using mice from the same strain, but if they have kept the colonies separate for a long time and have not taken care to refresh the colony with original individuals from the same supplier, the truth is that the mice will be genetically distinct, even though the researchers name them the same way and (erroneously) believe they are equivalent.

All of the above affects the genetic characteristics of each mouse model of a disease of biomedical interest. For the conclusions reached by two researchers using the same mouse strain for their respective experiments to be comparable, the animals they use must also be comparable. If, on the other hand, the colonies have been separated for some time and have accumulated various mutations, then it is very likely that the conclusions reached by the researchers will differ, even if they believe they are using the same strain of mice.

A study recently published in the journal Science by mouse geneticists in the U.S. highlights the underlying, and often unknown, of the mice used by researchers in biomedicine and calls into question the genetic purity of many mice stored in mouse repositories (in the form of cryopreserved sperm or embryos) under strain names and with the presence of certain genetic constructs that frequently do not correspond to the reality reflected in the descriptive name of those mice. The researchers analyzed the genomes of 611 individuals derived from 341 mouse strains deposited in the American MMRRC mouse repository and found that only 20% of them accurately correspond to the genetic characteristics indicated in the strain name. In the rest, they found additional genetic modifications, or the absence of modifications that should be present, or genetic variants indicating strain mixing.

This is a well-known fact that those of us responsible for mouse repositories continue to grapple with, trying to convince our colleagues to detail the genetic characteristics of the mice they report in any scientific article, explaining the genetic variants they possess, the genetic modifications introduced via transgenesis, mutation, or gene editing, so that those who use them later are not surprised to discover that they do not contain the genetic variants they should and, perhaps, contain others that should not be present. In Europe, through the European infrastructure INFRAFRONTIER, we have recently published recommendations for reporting in detail and with precision all the genetic characteristics of a mouse strain so that those who use them later know exactly what type of mice they are experimenting with.

The origin of the problem likely stems from the multitude of crosses of all kinds that have been carried out with the thousands of mouse strains created by the scientific community. If a mouse from strain A carries genetic modification 1 and we are interested in seeing the effect of another genetic modification 2 present in a mouse from strain B, then the standard practice has been to cross the two mice until, after several crosses and generations, genetic modifications 1 and 2 are present in the same individual. However, the strain of that mouse will then no longer be either A or B, but rather a mixture of the two genomes. And if we now send our mouse with the double genetic modification to a collaborator who wants to investigate the effect of a third genetic modification 3 present in strain C, then, after the appropriate crossings, we will end up with a mouse carrying the triple genetic modification but whose genetic variants in the genome are neither A, nor B, nor C, but a mixture of the three genomes. And researchers might expand their colony by crossing the mice with other A individuals and describe that mouse as A in their scientific publication, when in reality, if we were to investigate its genetic purity, we would find variants of B and C that were not in its name but are still present. This is an all-too-common error that contributes to variability in results and a lack of reproducibility, as the mice used may have other genetic variants unknown to the researcher.

This study in Science once again highlights a well-known problem that mouse geneticists strive to combat by every means possible, because it has a solution, recommending that periodic genetic tests be performed to verify at all times that we are truly working with the X strain mouse we believe we are working with, and that other mutations and genetic variants—which have not been reported but are present in the mice we are using—have not slipped in, contributing to genetic noise and variability. American researchers recommend the use of a genetic test they themselves helped develop, the MiniMUGA genetic quality test, but there are other ways to genetically validate a mouse’s purity, such as through whole-genome sequencing.

EN